Question

consider this claim: prescription drugs should not be advertised directly to consumers because of the potential risk of misinforming the public. which is the strongest evidence to support the claim? according to a study published in a medical journal, fifty - five percent of the claims made in drug ads to consumers were considered \potentially misleading\ and two percent were \false.\ researchers at dartmouth college analyzed pharmaceutical spending trends over a twenty - year span and found that spending on consumer direct - to - consumer advertisements increased from $2.1 billion in 1997 to $9.6 billion in 2016. a survey investigating the consumer impact of advertisements for prescription drugs found that one - third of respondents have asked their doctors for more information about a drug they learned about from an ad.

Explanation:

The claim focuses on direct-to-consumer prescription drug ads misinforming the public. The first option provides empirical data from a medical journal study showing 55% of ad claims are potentially misleading and 2% are false—directly linking ads to misinformation. The second option about spending trends is irrelevant to misinformation risk. The third option about consumers asking doctors for info does not indicate misinformation. Thus, the first option is the strongest evidence.

Answer:

According to a study published in a medical journal, fifty-five percent of the claims made in drug ads to consumers were considered "potentially misleading" and two percent were "false."